Prophylactic antibiotics versus standard care to prevent chest infection after acute stroke with dysphagia

Phase 4, randomised, open-label trial of amoxicillin, amoxicillin + clavulanate, clarithromycin, trimethoprim + sulfamethoxazole and metronidazole in stroke (2 arms), sponsored by King's College Hospital. Primary endpoints: Incidence of chest infections within 14 days after stroke onset and Total hospital costs for the initial episode of care. Started Oct 2007; status: completed.